Cagrilintide Reconstitution & Dosing
Also known as: Amylin analog, CagriSema component
Quick answer: mix a 5 mg vial of Cagrilintide with 2 ml of bacteriostatic water. That gives 2.50 mg/ml, so a typical 500 mcg dose is 20 units on a U-100 insulin syringe — about 10 doses per vial. Reported protocols range 250 mcg–2.4 mg, 1x weekly.
Cagrilintide is a long-acting amylin analog studied alongside semaglutide (as CagriSema) for appetite control through a separate satiety pathway. Often stacked with GLP-1s in research protocols. Full overview: what is Cagrilintide? →
Calculate your exact dose
Typical range: 250 mcg–2.4 mg, 1x weekly
Cagrilintide mixing chart — 5 mg vial
Units to draw for a 500 mcg dose at different water amounts. More water never changes the dose — only the volume you measure.
| Water added | Concentration | 500 mcg dose = | Per unit |
|---|---|---|---|
| 1 ml | 5.00 mg/ml | 10 units | 50.0 mcg |
| 2 ml ← typical | 2.50 mg/ml | 20 units | 25.0 mcg |
| 2.5 ml | 2.00 mg/ml | 25 units | 20.0 mcg |
| 3 ml | 1.67 mg/ml | 30 units | 16.7 mcg |
| 5 ml | 1.00 mg/ml | 50 units | 10.0 mcg |
Protocol reference
FAQ
How much bacteriostatic water do you add to Cagrilintide?+
Most protocols mix a 5 mg vial of Cagrilintide with 2 ml of bacteriostatic water. This gives 2.50 mg/ml, so a typical 500 mcg dose is 20 units on a U-100 insulin syringe. More or less water is fine — it only changes the volume you draw, not the dose.
What is a typical Cagrilintide dose?+
Commonly reported Cagrilintide protocols use 250 mcg to 2.4 mg, 1x weekly, administered via subcutaneous injection. These are reference figures from published protocols, not medical advice — individual use should be guided by a healthcare provider.
How many doses are in a 5 mg vial of Cagrilintide?+
At 500 mcg per dose, a 5 mg vial contains about 10 doses, regardless of how much water you add.
How should Cagrilintide be stored?+
Reconstituted: refrigerate; typically used within 4–8 weeks.
Related peptides
Educational reference only. Values reflect commonly published research protocols and are not medical advice or a recommendation to use any compound. Cagrilintide may not be approved for human use in your jurisdiction.